Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Glaucoma: Overview01:25

Glaucoma: Overview

560
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
560

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitreous Opacities in Familial Transthyretin Amyloidosis.

Deutsches Arzteblatt international·2025
Same author

A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases.

Journal of hepatocellular carcinoma·2024
Same author

Visualization of Keratopathy Associated With the Antibody-Drug Conjugate Belantamab Mafodotin Using Infrared Imaging in Patients With Multiple Myeloma.

Cornea·2024
Same author

Peripheral Ulcerative Keratitis: Clinical Characteristics, Differential Diagnoses and Therapeutic Concepts.

Klinische Monatsblatter fur Augenheilkunde·2024
Same author

[Correction: Peripheral ulcerative keratitis: Clinical characteristics, differential diagnoses and therapeutic concepts].

Klinische Monatsblatter fur Augenheilkunde·2024
Same author

[Surgical therapy and pathogen detection in endogenous endophthalmitis : Analysis of data from five German eye hospitals].

Die Ophthalmologie·2024
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Giant Cell Arteritis.

Thomas Ness1,2, Bernhard Nölle3

  • 1Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Deutschland.

Klinische Monatsblatter Fur Augenheilkunde
|April 9, 2024
PubMed
Summary
This summary is machine-generated.

Giant cell arteritis (GCA) requires prompt diagnosis and treatment to prevent vision loss. Ophthalmologists should suspect GCA with specific eye symptoms and initiate immediate evaluation and therapy.

More Related Videos

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.7K
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

15.3K

Related Experiment Videos

Last Updated: Jun 28, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K
Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.7K
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
10:05

Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro

Published on: January 25, 2017

15.3K

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is the most common primary vasculitis, posing a significant risk of bilateral blindness.
  • Diagnosis of GCA is challenging due to the lack of simple, unequivocal clinical or laboratory markers, necessitating rapid and reliable management.
  • Ocular symptoms such as visual loss, transient visual disturbances (amaurosis fugax), diplopia, eye pain, and new-onset head or jaw claudication are critical indicators for ophthalmologists.

Purpose of the Study:

  • To summarize current diagnostic and therapeutic recommendations for Giant Cell Arteritis (GCA) relevant to ophthalmology.
  • To highlight the importance of early recognition and intervention in preventing vision loss associated with GCA.
  • To discuss advancements in diagnostic imaging and therapeutic strategies for GCA.

Main Methods:

  • Immediate ophthalmological examination including slit lamp, ophthalmoscopy, and visual field testing.
  • Color duplex ultrasound of the temporal artery as a key diagnostic tool.
  • Consideration of corticosteroid therapy initiation upon clinical suspicion, followed by referral and potential temporal artery biopsy.

Main Results:

  • Modern imaging techniques like color duplex ultrasonography, MRI, and PET-CT offer alternatives to traditional temporal artery biopsy.
  • Early determination of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) can aid in diagnosis.
  • Revised classification criteria and recommendations from the American College of Rheumatology and European League Against Rheumatism incorporate these advancements.

Conclusions:

  • Prompt ophthalmological evaluation and initiation of corticosteroid therapy are crucial for patients with suspected GCA to prevent irreversible vision loss.
  • Advanced imaging modalities and inflammatory markers (ESR, CRP) supplement clinical suspicion and biopsy in diagnosing GCA.
  • Steroid-sparing immunosuppressive therapies, including IL-6 blockade and methotrexate, represent important therapeutic options alongside corticosteroids.